Shufro Rose & CO LLC Enzo Biochem Inc Transaction History
Shufro Rose & CO LLC
- $1.19 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding ENZ
# of Institutions
7Shares Held
3.92MCall Options Held
0Put Options Held
0-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
-
Black Rock Inc. New York, NY955KShares$525,2620.0% of portfolio
-
Lepercq Multi Asset Fund Hamilton, D0123KShares$67,6500.06% of portfolio
-
Raymond James Trust N.A.17KShares$9,3580.0% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...